| Bioactivity | HSD17B13-IN-9 (252) is a 17β-Hydroxysteroid dehydrogenases (HSD17B13) inhibitor, with an IC50 of 0.01 μM for 50 nM HSD17B13. Used in NAFLD (Nonalcoholic fatty liver diseases) research[1]. |
| Name | HSD17B13-IN-9 |
| CAS | 2576690-78-1 |
| Formula | C22H17F3N2O2S |
| Molar Mass | 430.44 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Joseph Vacca, et al. Modulators of hsd17b13 and methods of use thereof. Patent WO2021003295. |
HSD17B13-IN-9
CAS: 2576690-78-1 F: C22H17F3N2O2S W: 430.44
HSD17B13-IN-9 (252) is a 17β-Hydroxysteroid dehydrogenases (HSD17B13) inhibitor, with an IC50 of 0.01 μM for 50 nM HSD
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.